Effective when combined with a healthy diet and exercise
Significant reduction in blood sugar levels for individuals with type 2 diabetes
Substantial weight loss results, with at least 20% body weight loss achieved within a year of treatment
This product is out of stock.
Product is not available in this quantity.
$ 1,200 USD
Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus.
Frequently Asked Questions
What is tirzepatide
Tirzepatide (Mounjaro) is an FDA-approved weekly injection used for type 2 diabetes to lower blood sugar. Tirzepatide has also been shown in clinical trials to be useful for weight loss, although currently it is not an FDA-approved weight loss drug. Tirzepatide works by activating the GIP and GLP-1 receptors. Tirzepatide is only indicated for adults and should be used along with diet and exercise.